Your browser doesn't support javascript.
loading
Corrigendum: Patients with myeloproliferative neoplasms harbor high frequencies of CD8 T cell-platelet aggregates associated with T cell suppression.
Simões, Ana Micaela Carnaz; Holmström, Morten Orebo; Aehnlich, Pia; Rahbech, Anne; Peeters, Marlies J W; Radziwon-Balicka, Aneta; Zamora, Carlos; Klausen, Tobias Wirenfeldt; Skov, Vibe; Kjær, Lasse; Ellervik, Christina; Fassi, Daniel El; Vidal, Silvia; Hasselbalch, Hans Carl; Andersen, Mads Hald; Straten, Per Thor.
Afiliación
  • Simões AMC; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Herlev University Hospital, Herlev, Denmark.
  • Holmström MO; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Herlev University Hospital, Herlev, Denmark.
  • Aehnlich P; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Herlev University Hospital, Herlev, Denmark.
  • Rahbech A; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Herlev University Hospital, Herlev, Denmark.
  • Peeters MJW; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Herlev University Hospital, Herlev, Denmark.
  • Radziwon-Balicka A; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Herlev University Hospital, Herlev, Denmark.
  • Zamora C; IIB-Sant Pau- Institut Rec. Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Klausen TW; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Herlev University Hospital, Herlev, Denmark.
  • Skov V; Department of Hematology, Zealand University Hospital, Roskilde, Denmark.
  • Kjær L; Department of Hematology, Zealand University Hospital, Roskilde, Denmark.
  • Ellervik C; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Fassi DE; Department of Laboratory Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA, United States.
  • Vidal S; Department of Data and Innovation Support, Region Zealand, Sorø, Denmark.
  • Hasselbalch HC; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Andersen MH; Department of Hematology, Rigshospitalet University Hospital, Copenhagen, Denmark.
  • Straten PT; IIB-Sant Pau- Institut Rec. Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Front Immunol ; 13: 970322, 2022.
Article en En | MEDLINE | ID: mdl-35990670
[This corrects the article DOI: 10.3389/fimmu.2022.866610.].
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Dinamarca Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Dinamarca Pais de publicación: Suiza